Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1627 1642 1644 1645
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18576149 | PREPARATION OF SUBSTITUTED AMIDOXIMES | Non-Final OA | BASF SE |
| 18558423 | TREATMENT OF PHARMACORESISTANT EPILEPSY | Non-Final OA | Katholieke Universiteit Leuven |
| 18071724 | COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT | Non-Final OA | Northwestern University |
| 15764187 | CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AS THERAPEUTIC INTERVENTIONS FOR AUTO- AND ALLO-IMMUNITY | Non-Final OA | Regents of the University of Minnesota |
| 17895280 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELIN RELATED AND INFLAMMATION RELATED DISEASES OR DISORDERS | Final Rejection | Duke University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy